title: Nanomedical research in Australia and New Zealand.
abstract: Although Australia and New Zealand have a combined population of less than 30 million, they have an active and interlinked community of nanomedical researchers. This report provides a synopsis and update on this network with a view to identifying the main topics of interest and their likely future trajectories. In addition, our report may also serve to alert others to opportunities for joint projects. Australian and New Zealand researchers are engaged in most of the possible nanomedical topics, but the majority of interest is focused on drug and nucleic acid delivery using nanoparticles or nanoporous constructs. There are, however, smaller programs directed at hyperthermal therapy and radiotherapy, various kinds of diagnostic tests and regenerative technologies.
authors.affiliation: Institute for Nanoscale Technology, University of Technology Sydney, PO Box 123, Broadway, NSW 2007, Sydney, Australia.
authors.forename: Michael B
authors.initials: MB
authors.lastname: Cortie
authors.forename: Eman H
authors.initials: EH
authors.lastname: Nafea
authors.forename: Hui
authors.initials: H
authors.lastname: Chen
authors.forename: Stella M
authors.initials: SM
authors.lastname: Valenzuela
authors.forename: Sr Simon
authors.initials: SS
authors.lastname: Ting
authors.forename: Fabio
authors.initials: F
authors.lastname: Sonvico
authors.forename: Bruce
authors.initials: B
authors.lastname: Milthorpe
mesh_terms: D001315:Australia; D019937:Diagnostic Techniques and Procedures; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D050997:Nanomedicine / Q000379:methods; D049329:Nanostructures / Q000737:chemistry / Q000627:therapeutic use; D009520:New Zealand; D009696:Nucleic Acids / Q000008:administration & dosage*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D044968:Regenerative Medicine / Q000379:methods
chemical_list: D009696:Nucleic Acids; D004364:Pharmaceutical Preparations